Keyword

AQ4N

Description: AQ4N, also known as banoxantrone, is an experimental bioreductive anticancer drug designed to become active under low-oxygen conditions in tumors.
Wikidata ID: wiki/Q27292332
OpenAlex ID: keywords/aq4n
2000 · L H Patterson, S R McKeown · British Journal of Cancer · 190
2008 · Mark R. Albertella, Paul M. Loadman, et al. · Clinical Cancer Research · 143
2002 · Laurence Patterson, Graeme Murray · Current Pharmaceutical Design · 136
2018 · Yannan Yang, Yao Lu, et al. · Advanced Functional Materials · 125
2010 · Clinton R. Nishida, Melody Lee, et al. · Molecular Pharmacology · 118
1999 · L H Patterson, S R McKeown, et al. · PubMed · 96
2008 · Brian Fitzpatrick, Manal Mehibel, et al. · Nitric Oxide · 88
2000 · L H Patterson, K Ruparelia, et al. · British Journal of Cancer · 86
1998 · S.M Raleigh, E Wanogho, et al. · International Journal of Radiation Oncology*Biology*Physics · 83
2004 · P. Rooney, C. Telfer, et al. · Current Cancer Drug Targets · 82
2002 · Helen O McCarthy, Anita Yakkundi, et al. · Cancer Gene Therapy · 64
2000 · Alan E. Lee, William R. Wilson · Toxicology and Applied Pharmacology · 62
Works count: 147
Citation count: 4,634
Year
Topic
Type